News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
219 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28725)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (102)
4 (174)
5 (247)
6 (211)
7 (265)
8 (238)
11 (138)
12 (205)
13 (219)
14 (240)
15 (174)
18 (169)
19 (181)
20 (151)
21 (144)
22 (81)
23 (1)
25 (165)
26 (154)
27 (94)
28 (19)
29 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
23
25
26
27
28
29
Manufacturing
Novo-Catalent Deal Represents ‘Defining Moment’ for CDMO Sector
Novo Holdings’ acquisition of Catalent has ignited concerns from industry stakeholders, who fear that the consolidation could limit competition, but there is also the possibility that the deal could represent an opportunity for smaller-scale CDMOs to find new partners.
November 13, 2024
·
4 min read
·
Ben Hargreaves
Press Releases
Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development
November 13, 2024
·
7 min read
Press Releases
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
November 13, 2024
·
4 min read
Press Releases
Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data
November 13, 2024
·
13 min read
Press Releases
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
November 13, 2024
·
2 min read
Press Releases
Quantum-Si Reports Third Quarter 2024 Financial Results
November 13, 2024
·
13 min read
Press Releases
Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024
November 13, 2024
·
5 min read
Press Releases
CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024
·
5 min read
Press Releases
Collegium to Participate in Upcoming Investor Conferences
November 13, 2024
·
1 min read
Press Releases
MediWound to Report Third Quarter 2024 Financial Results
November 13, 2024
·
1 min read
1 of 22
Next
